Latham & Watkins represented Boston Scientific Corporation in the transaction, and Wilson Sonsini Goodrich & Rosati represented Silk Road Medical. Boston Scientific Corporation (“Boston Scientific”) (NYSE:...
Boston Scientific’s $1.26 Billion Acquisition of Silk Road
Talkiatry’s $130 Million Series C Financing Round
Wilson Sonsini Goodrich & Rosati advised a16z on the transaction. Talkiatry, a leading provider of high-quality, in-network psychiatric care, announced the completion of a $130 million...
H.I.G. Growth’s Acquisition of Mobile Health
Wilson Sonsini Goodrich & Rosati advised Mobile Health on the transaction, while Paul Hastings and Bass, Berry & Sims advised H.I.G. Growth Partners. H.I.G. Growth Partners...
Ochre Bio’s $37.5 Million License Agreement with GSK
Wilson Sonsini Goodrich & Rosati represented Ochre Bio in the transaction. Ochre Bio, a pioneer in chronic liver disease medicine development, announced the start of a...
ArteraAI’s $20 Million Funding Round
Wilson Sonsini Goodrich & Rosati advised ArteraAI on the transaction. ArteraAI announced it has secured an additional $20 million in capital fueled by several prominent large...
L Catterton’s $680 Million Acquisition of Thorne HealthTech
Kirkland & Ellis LLP is representing L Catterton, and Wilson Sonsini Goodrich & Rosati is representing Thorne HealthTech, Inc. in the transaction. Thorne HealthTech, Inc. (“Thorne”)...
Transcarent’s Acquisition of 98point6 AI-Powered Virtual Care Platform
Wilson Sonsini Goodrich & Rosati represented Transcarent in the transaction. Transcarent, a health and care experience company that makes it easy for people to access high-quality,...
GE HealthCare’s Acquisition of Caption Health
Wilson Sonsini Goodrich & Rosati advised Caption Health on the acquisition. GE HealthCare, a leading global precision care innovator, announced that it has signed an agreement...